The effect of combined training with Zataria multiflora supplementation on lipid profile and some cardiovascular risk factors in inactive men

The effect of eight weeks of combined training with Zataria multiflora supplementation on ANGPTL3, ANGPTL4, ANGPTL8, lipid profile and some cardiovascular risk factors in inactive men

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211107052994N1

Enrollment

Registered

2021-11-25

Start date

2021-11-26

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inactive men.

Interventions

Intervention 1: Control group: Failure to participate in the combined exercise program, consumption of placebo capsules for 8 weeks with the content of wheat flour made by Gol Daroo company in additio

Eligibility

Sex/Gender

Male

Age

25 Years to 37 Years

Inclusion criteria

Inclusion criteria: No cardiovascular disease and diabetes Not participating in physical activity in the past year No physical and medical restrictions for exercising

Exclusion criteria

Exclusion criteria: Alcohol and drug use Allergy toZataria multiflora supplements Taking supplements or medications in the last 6 months

Design outcomes

Primary

Measure	Time frame
Angiopoietin-like protein 3(ANGPTL3). Timepoint: First, the end of the study. Method of measurement: Elisa Kit.;Angiopoietin-like protein 4(ANGPTL4). Timepoint: First, the end of the study. Method of measurement: Elisa Kit.;Angiopoietin-like protein 8(ANGPTL8). Timepoint: First, the end of the study. Method of measurement: Elisa Kit.;Total cholesterol. Timepoint: First, the end of the study. Method of measurement: Plasma serum.;Tri glyceride(TG). Timepoint: First, the end of the study. Method of measurement: Plasma serum.;C-Reactive Protein (CRP). Timepoint: First, the end of the study. Method of measurement: Bionic Kit.	—

Measure

Time frame

Angiopoietin-like protein 3(ANGPTL3). Timepoint: First, the end of the study. Method of measurement: Elisa Kit.;Angiopoietin-like protein 4(ANGPTL4). Timepoint: First, the end of the study. Method of measurement: Elisa Kit.;Angiopoietin-like protein 8(ANGPTL8). Timepoint: First, the end of the study. Method of measurement: Elisa Kit.;Total cholesterol. Timepoint: First, the end of the study. Method of measurement: Plasma serum.;Tri glyceride(TG). Timepoint: First, the end of the study. Method of measurement: Plasma serum.;C-Reactive Protein (CRP). Timepoint: First, the end of the study. Method of measurement: Bionic Kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Sadeghi

Islamic Azad University

arash12601@yahoo.com+98 21 4499 7017

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026